Sign In
Buy PCRX
$22.32
+0.0700 (+0.315%)
At Close: Jun 03, 2026
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 17)
Catalent Inc (NYSE: CTLT)
CureVac N.V. (NASDAQ: CVAC) (follow-on buying after a 250% advance on its debut Friday...
Pacira Biosciences (NASDAQ:PCRX) Hits New 12-Month High on Analyst Upgrade
01:24am, Tuesday, 11'th Aug 2020
Pacira Biosciences Inc (NASDAQ:PCRX)’s stock price reached a new 52-week high on Monday after HC Wainwright raised their price target on the stock from $68.00 to $70.00. HC Wainwright currently has
Stocks To Watch: Barrick Gold, Hedge Fund Reveals And Election Plays (NASDAQ:ACIA)
12:08pm, Saturday, 08'th Aug 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday
Ocular Therapeutix™ Reports Second Quarter 2020 Financial Results and Business Update
12:00am, Friday, 07'th Aug 2020
Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative the
Pacira BioSciences Reports Second Quarter 2020 Financial Results and Business Update
12:00pm, Thursday, 06'th Aug 2020
\-- EXPAREL average daily sales return to year-over-year growth in month of June 2020 -- \-- Conference call today at 8:30 a.m. ET --PARSIPPANY, N.J., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Pacira BioScie
Pacira BioSciences to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference
08:05pm, Wednesday, 05'th Aug 2020
PARSIPPANY, N.J., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will present at the 2020 Wedbush PacGrow Healthcare Virtual Conference at 9:10 AM E
Pacira Announces Publication of Phase 4 Study of EXPAREL in Cesarean Section Procedures in Anesthesia & Analgesia
11:30am, Wednesday, 05'th Aug 2020
– Results show an opioid-reducing benefit of adding EXPAREL to bupivacaine transversus abdominis plane (TAP) blocks for cesarean delivery –PARSIPPANY, N.J., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Pacir
Pacira BioSciences Announces FDA Acceptance of sNDA for EXPAREL Use in Pediatric Patients
11:30am, Tuesday, 04'th Aug 2020
sNDA submission based on positive Phase 3 data supporting expansion of the EXPAREL label to include use in children aged six and overPARSIPPANY, N.J., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Pacira BioScien
Pacira to Report Second Quarter 2020 Financial Results on Thursday August 6, 2020
11:30am, Thursday, 30'th Jul 2020
PARSIPPANY, N.J., July 30, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its second quarter financial results before the open of the U.S. markets
The Daily Biotech Pulse: Merck's Breakthrough Therapy Designation, Sonoma Surges On Sanitizer News, Sanofi-Glaxo And More
12:00am, Wednesday, 29'th Jul 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 28)
Axonics Modulation Technologies Inc (NASDAQ: AXNX)
Capricor Therapeutics Inc (NASDAQ: CAPR)
Fulgent Genetics Inc...
Pacira BioSciences Announces Settlement of Government Investigation
09:03pm, Tuesday, 28'th Jul 2020
Pacira to Pay $3.5 Million to Settle Various Claims with No Admission of WrongdoingPARSIPPANY, N.J., July 28, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), a leading provider of in
State Street Corp Grows Position in Pacira Biosciences Inc (NASDAQ:PCRX)
07:00am, Tuesday, 21'st Jul 2020
State Street Corp grew its stake in shares of Pacira Biosciences Inc (NASDAQ:PCRX) by 5.6% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 1,403,659 shares of the com
Brokerages Expect Pacira Biosciences Inc (NASDAQ:PCRX) Will Announce Quarterly Sales of $75.50 Million
01:20am, Sunday, 19'th Jul 2020
Equities research analysts expect Pacira Biosciences Inc (NASDAQ:PCRX) to post $75.50 million in sales for the current quarter, according to Zacks. Four analysts have provided estimates for Pacira Bio
Royal Bank of Canada Boosts Stock Holdings in Pacira Biosciences Inc (NASDAQ:PCRX)
05:13am, Saturday, 18'th Jul 2020
Royal Bank of Canada grew its stake in shares of Pacira Biosciences Inc (NASDAQ:PCRX) by 73.7% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fi
Ocular Therapeutix Presents at the 12th Annual Ophthalmology Innovation Summit (OIS)
12:00am, Friday, 17'th Jul 2020
Ocular Therapeutix, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative ther
